Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3S7WUH0
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0016787 | hydrolase activity | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 145 | 147 | PF00675 | 0.505 |
CLV_NRD_NRD_1 | 240 | 242 | PF00675 | 0.470 |
CLV_NRD_NRD_1 | 282 | 284 | PF00675 | 0.551 |
CLV_PCSK_KEX2_1 | 240 | 242 | PF00082 | 0.470 |
CLV_PCSK_KEX2_1 | 281 | 283 | PF00082 | 0.472 |
CLV_PCSK_KEX2_1 | 43 | 45 | PF00082 | 0.512 |
CLV_PCSK_PC1ET2_1 | 281 | 283 | PF00082 | 0.472 |
CLV_PCSK_PC1ET2_1 | 43 | 45 | PF00082 | 0.457 |
CLV_PCSK_SKI1_1 | 164 | 168 | PF00082 | 0.508 |
CLV_PCSK_SKI1_1 | 234 | 238 | PF00082 | 0.435 |
CLV_PCSK_SKI1_1 | 286 | 290 | PF00082 | 0.601 |
DEG_SCF_FBW7_1 | 122 | 129 | PF00400 | 0.378 |
DOC_CKS1_1 | 123 | 128 | PF01111 | 0.371 |
DOC_CYCLIN_yCln2_LP_2 | 171 | 177 | PF00134 | 0.496 |
DOC_MAPK_gen_1 | 144 | 151 | PF00069 | 0.588 |
DOC_MAPK_MEF2A_6 | 273 | 280 | PF00069 | 0.572 |
DOC_PP2B_LxvP_1 | 219 | 222 | PF13499 | 0.377 |
DOC_USP7_MATH_1 | 159 | 163 | PF00917 | 0.461 |
DOC_USP7_MATH_1 | 177 | 181 | PF00917 | 0.448 |
DOC_USP7_UBL2_3 | 310 | 314 | PF12436 | 0.667 |
DOC_USP7_UBL2_3 | 315 | 319 | PF12436 | 0.709 |
DOC_WW_Pin1_4 | 122 | 127 | PF00397 | 0.369 |
LIG_14-3-3_CanoR_1 | 106 | 114 | PF00244 | 0.477 |
LIG_APCC_ABBA_1 | 230 | 235 | PF00400 | 0.503 |
LIG_BRCT_BRCA1_1 | 297 | 301 | PF00533 | 0.575 |
LIG_Clathr_ClatBox_1 | 120 | 124 | PF01394 | 0.409 |
LIG_Clathr_ClatBox_1 | 17 | 21 | PF01394 | 0.377 |
LIG_DLG_GKlike_1 | 116 | 123 | PF00625 | 0.480 |
LIG_EH1_1 | 114 | 122 | PF00400 | 0.458 |
LIG_FHA_1 | 1 | 7 | PF00498 | 0.624 |
LIG_FHA_1 | 123 | 129 | PF00498 | 0.365 |
LIG_FHA_1 | 30 | 36 | PF00498 | 0.602 |
LIG_HCF-1_HBM_1 | 201 | 204 | PF13415 | 0.540 |
LIG_HP1_1 | 16 | 20 | PF01393 | 0.504 |
LIG_LIR_Gen_1 | 88 | 99 | PF02991 | 0.400 |
LIG_LIR_Nem_3 | 201 | 207 | PF02991 | 0.414 |
LIG_LIR_Nem_3 | 235 | 239 | PF02991 | 0.422 |
LIG_LIR_Nem_3 | 88 | 94 | PF02991 | 0.393 |
LIG_LIR_Nem_3 | 98 | 102 | PF02991 | 0.325 |
LIG_Pex14_1 | 270 | 274 | PF04695 | 0.402 |
LIG_REV1ctd_RIR_1 | 234 | 241 | PF16727 | 0.459 |
LIG_SH2_CRK | 99 | 103 | PF00017 | 0.346 |
LIG_SH2_PTP2 | 204 | 207 | PF00017 | 0.418 |
LIG_SH2_SRC | 182 | 185 | PF00017 | 0.542 |
LIG_SH2_SRC | 204 | 207 | PF00017 | 0.437 |
LIG_SH2_STAP1 | 182 | 186 | PF00017 | 0.450 |
LIG_SH2_STAP1 | 45 | 49 | PF00017 | 0.445 |
LIG_SH2_STAT5 | 204 | 207 | PF00017 | 0.397 |
LIG_SH3_3 | 146 | 152 | PF00018 | 0.477 |
LIG_SH3_3 | 210 | 216 | PF00018 | 0.467 |
LIG_SH3_3 | 220 | 226 | PF00018 | 0.428 |
LIG_SH3_3 | 56 | 62 | PF00018 | 0.374 |
LIG_SUMO_SIM_anti_2 | 119 | 125 | PF11976 | 0.438 |
LIG_SUMO_SIM_par_1 | 119 | 125 | PF11976 | 0.434 |
LIG_SUMO_SIM_par_1 | 15 | 21 | PF11976 | 0.369 |
LIG_TRAF2_1 | 37 | 40 | PF00917 | 0.571 |
MOD_CK1_1 | 162 | 168 | PF00069 | 0.480 |
MOD_CK2_1 | 162 | 168 | PF00069 | 0.404 |
MOD_CK2_1 | 177 | 183 | PF00069 | 0.499 |
MOD_CK2_1 | 63 | 69 | PF00069 | 0.537 |
MOD_GlcNHglycan | 164 | 167 | PF01048 | 0.549 |
MOD_GlcNHglycan | 187 | 190 | PF01048 | 0.562 |
MOD_GlcNHglycan | 255 | 258 | PF01048 | 0.500 |
MOD_GlcNHglycan | 28 | 32 | PF01048 | 0.603 |
MOD_GlcNHglycan | 297 | 300 | PF01048 | 0.595 |
MOD_GSK3_1 | 122 | 129 | PF00069 | 0.366 |
MOD_GSK3_1 | 240 | 247 | PF00069 | 0.552 |
MOD_NEK2_1 | 107 | 112 | PF00069 | 0.397 |
MOD_NEK2_1 | 167 | 172 | PF00069 | 0.504 |
MOD_NEK2_1 | 187 | 192 | PF00069 | 0.521 |
MOD_NEK2_1 | 20 | 25 | PF00069 | 0.404 |
MOD_NEK2_1 | 27 | 32 | PF00069 | 0.514 |
MOD_NEK2_1 | 294 | 299 | PF00069 | 0.505 |
MOD_NEK2_1 | 48 | 53 | PF00069 | 0.500 |
MOD_NEK2_1 | 63 | 68 | PF00069 | 0.545 |
MOD_NEK2_1 | 73 | 78 | PF00069 | 0.324 |
MOD_NEK2_1 | 95 | 100 | PF00069 | 0.344 |
MOD_NEK2_2 | 159 | 164 | PF00069 | 0.495 |
MOD_NEK2_2 | 177 | 182 | PF00069 | 0.213 |
MOD_PKA_1 | 240 | 246 | PF00069 | 0.449 |
MOD_PKA_2 | 133 | 139 | PF00069 | 0.544 |
MOD_PKA_2 | 240 | 246 | PF00069 | 0.449 |
MOD_Plk_1 | 154 | 160 | PF00069 | 0.481 |
MOD_Plk_1 | 167 | 173 | PF00069 | 0.445 |
MOD_Plk_1 | 177 | 183 | PF00069 | 0.415 |
MOD_Plk_1 | 20 | 26 | PF00069 | 0.503 |
MOD_Plk_4 | 1 | 7 | PF00069 | 0.520 |
MOD_Plk_4 | 116 | 122 | PF00069 | 0.376 |
MOD_Plk_4 | 177 | 183 | PF00069 | 0.483 |
MOD_Plk_4 | 187 | 193 | PF00069 | 0.440 |
MOD_Plk_4 | 240 | 246 | PF00069 | 0.449 |
MOD_ProDKin_1 | 122 | 128 | PF00069 | 0.370 |
TRG_DiLeu_BaEn_1 | 290 | 295 | PF01217 | 0.494 |
TRG_ENDOCYTIC_2 | 204 | 207 | PF00928 | 0.402 |
TRG_ENDOCYTIC_2 | 45 | 48 | PF00928 | 0.426 |
TRG_ENDOCYTIC_2 | 99 | 102 | PF00928 | 0.345 |
TRG_ER_diArg_1 | 239 | 241 | PF00400 | 0.466 |
TRG_ER_diArg_1 | 282 | 284 | PF00400 | 0.551 |
TRG_ER_diLys_1 | 317 | 322 | PF00400 | 0.682 |
TRG_NLS_MonoExtN_4 | 315 | 322 | PF00514 | 0.788 |
TRG_Pf-PMV_PEXEL_1 | 179 | 183 | PF00026 | 0.480 |
TRG_Pf-PMV_PEXEL_1 | 208 | 212 | PF00026 | 0.494 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBS7 | Leptomonas seymouri | 76% | 77% |
A0A0S4J8H7 | Bodo saltans | 40% | 77% |
A0A1X0NUK7 | Trypanosomatidae | 54% | 81% |
A0A422N4J3 | Trypanosoma rangeli | 54% | 85% |
A4H908 | Leishmania braziliensis | 87% | 100% |
A4HXE0 | Leishmania infantum | 98% | 100% |
C9ZU35 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 85% |
E9AR35 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
Q4QEC8 | Leishmania major | 96% | 100% |
V5API2 | Trypanosoma cruzi | 55% | 85% |